Privia Health Group, Inc. (PRVA) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers the 2026 Annual Meeting of Stockholders held by Privia Health Group, Inc. on May 20, 2026. The meeting was conducted via live webcast.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters and voting results.
Material Changes and Voting Results
Stockholders approved all three proposals submitted at the Annual Meeting:
- Proposal 1 (Election of Directors): Three Class I directors were elected for a term expiring at the 2029 Annual Meeting.
- Nancy Cocozza: 103,661,977 votes for; 2,213,903 withheld.
- David King: 99,267,027 votes for; 6,608,853 withheld.
- Francis Soistman: 105,602,389 votes for; 273,491 withheld.
- Proposal 2 (Executive Compensation): Stockholders approved the compensation of named executive officers on an advisory, non-binding basis.
- Votes For: 103,956,500
- Votes Against: 1,813,934
- Abstentions: 105,446
- Proposal 3 (Auditor Ratification): Stockholders ratified the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
- Votes For: 117,343,159
- Votes Against: 8,578
- Abstentions: 73,653
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Confirmation of the new board composition and the specific terms of the elected Class I directors.
- Verification of the low vote count against executive compensation (1,813,934 votes against) relative to the total votes cast.
- Confirmation that PricewaterhouseCoopers LLP will serve as the auditor for the fiscal year ending December 31, 2026.
- Review of the full proxy statement for detailed biographical information on the newly elected directors.